Literature DB >> 6105342

Propranolol--a medical treatment for portal hypertension?

D Lebrec, O Nouel, M Corbic, J P Benhamou.   

Abstract

Continuous, oral administration of propranolol at doses which reduced the heart-rate by 25% produced a sustained decrease in portal venous pressure in cirrhotic patients with portal hypertension. This effect of propranolol might be useful in preventing recurrent bleeding due to ruptured oesophageal varices in patients with portal hypertension.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6105342     DOI： 10.1016/s0140-6736(80)90063-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  56 in total

Review 1.  Pathophysiology and epidemiology of portal hypertension.

Authors:  H Okumura; T Aramaki; Y Katsuta
Journal:  Drugs       Date:  1989       Impact factor: 9.546

Review 2.  Portal hypertension--25 years of progress.

Authors:  B R MacDougall; D Westaby; L A Blendis
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 3.  Meta-analysis. A review of its place in therapeutic decision making.

Authors:  M Gibaldi
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

4.  Propranolol and HBsAg-positive cirrhosis.

Authors:  L Pagliaro; L Pasta; G D'Amico; M Traina; F Tinè
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

Review 5.  Is it time to replace propranolol with carvedilol for portal hypertension?

Authors:  Shahab Abid; Saadat Ali; Muhammad Asif Baig; Anam Akbar Waheed
Journal:  World J Gastrointest Endosc       Date:  2015-05-16

6.  Hemodynamic effect of propranolol on portal hypertension in patients with HBsAg-positive cirrhosis.

Authors:  C W Kong; C S Lay; Y T Tsai; S D Lee; K H Lai; K J Lo; B N Chiang
Journal:  Dig Dis Sci       Date:  1986-12       Impact factor: 3.199

7.  Endoscopic variceal pressure measurements: response to isosorbide dinitrate.

Authors:  J Dawson; P Gertsch; F Mosimann; R West; E Elias
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

8.  Sildenafil does not influence hepatic venous pressure gradient in patients with cirrhosis.

Authors:  Jens-Otto Clemmesen; Annamaria Giraldi; Peter Ott; Kim Dalhoff; Bent-Adel Hansen; Fin-Stolze Larsen
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

9.  Percutaneous transhepatic occlusion for bleeding oesophageal varices in polycystic disease.

Authors:  I A Laing; T A Buist; M S Fraser
Journal:  Arch Dis Child       Date:  1981-12       Impact factor: 3.791

10.  Effect of beta-blocking drugs on beta-cell function and insulin sensitivity in hypertensive non-diabetic patients.

Authors:  K Tötterman; L Groop; P H Groop; R Kala; E M Tolppanen; F Fyhrquist
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.